Journal article · 2023

Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease

Anna M Rios, Claire W. Chen, Etienne D. Jacotot, Carol M. Troy

Alzheimer s & Dementia, 19(S21), e077194 · Published 1 December 2023 · DOI 10.1002/alz.077194

View at the publisherCite this paper

In brief

“Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease” is a 2023 journal article by Anna M Rios and 3 co-authors, published in Alzheimer s & Dementia. OpenAlex counts 1 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2024 (1)
Field-weighted impact
0.09
Authors
4

Abstract

Background The enzyme caspase‐2 plays a central role in cellular apoptosis and is involved in the early stages of β‐amyloid 42 and tau deposition, making it a promising therapeutic target for Alzheimer’s Disease (AD). Caspase‐2 is highly expressed in the brains of patients with AD (1, 4) and those with mild cognitive impairment, which often… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rios, A. M., Chen, C. W., Jacotot, E. D., & Troy, C. M. (2023). Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease. Alzheimer s & Dementia, 19(S21), e077194. https://doi.org/10.1002/alz.077194

MLA 9

Rios, Anna M, et al. “Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease.” Alzheimer s & Dementia, vol. 19, no. S21, 2023, p. e077194. https://doi.org/10.1002/alz.077194.

Chicago

Rios, Anna M, Claire W. Chen, Etienne D. Jacotot, and Carol M. Troy. 2023. “Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease.” Alzheimer s & Dementia 19 (S21): e077194. https://doi.org/10.1002/alz.077194.

Harvard

Rios, A. M. et al. (2023) ‘Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease’, Alzheimer s & Dementia, 19(S21), p. e077194. doi:10.1002/alz.077194.

IEEE

A. M. Rios, C. W. Chen, E. D. Jacotot, and C. M. Troy, “Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease,” Alzheimer s & Dementia, vol. 19, no. S21, p. e077194, 2023, doi: 10.1002/alz.077194.

BibTeX

@article{rios2023caspase,
  title     = {{Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease}},
  author    = {Rios, Anna M and Chen, Claire W. and Jacotot, Etienne D. and Troy, Carol M.},
  journal   = {Alzheimer s \& Dementia},
  year      = {2023},
  volume    = {19},
  number    = {S21},
  pages     = {e077194},
  doi       = {10.1002/alz.077194},
  url       = {https://doi.org/10.1002/alz.077194}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Rios, A. M., Chen, C. W., Jacotot, E. D., & Troy, C. M. (2023). Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease. Alzheimer s & Dementia, 19(S21), e077194. https://doi.org/10.1002/alz.077194

How many times has this paper been cited?

1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Anna M Rios, Claire W. Chen, Etienne D. Jacotot, Carol M. Troy.

What is the DOI of this paper?

10.1002/alz.077194, permanently at https://doi.org/10.1002/alz.077194. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.